Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Björn Tackenberg

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Ebiomedicine|January 17, 2018
Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial)Björn Tackenberg, Maximilian Schneider, Franz Blaes, et al.
The Journal of Clinical Investigation|October 6, 2015
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicityIsaak Quast, Christian W Keller, Michael A Maurer, et al.
Frontiers in Immunology|July 12, 2019
Thymoma-Associated Paraneoplastic Autoimmune Multiorgan Syndrome-From Pemphigus to Lichenoid DermatitisFarzan Solimani, Roberto Maglie, Robert Pollmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2011
Sibling disability risk at onset and during disease progression in familial multiple sclerosisAnne Wellek, Catharina Korsukewitz, Jan P Bach, et al.
International Immunology|January 8, 2011
Impaired IFN-γ production and proliferation of NK cells in multiple sclerosisAnna Lünemann, Björn Tackenberg, Tracy DeAngelis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2025
Speech as a digital biomarker in multiple sclerosis: Automatic analysis of speech metrics using a multi-speech-task protocol in a cross-sectional MS cohort studySusett Garthof, Simona Schäfer, Julia Elmers, et al.
BMC Neurology|July 14, 2016
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumabTjalf Ziemssen, Achim Gass, Jens Wuerfel, et al.
Journal of Neurology|February 18, 2016
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological SocietyNico Melzer, Tobias Ruck, Peter Fuhr, et al.
The New England Journal of Medicine|July 13, 2012
Potassium channel KIR4.1 as an immune target in multiple sclerosisRajneesh Srivastava, Muhammad Aslam, Sudhakar Reddy Kalluri, et al.
Experimental Neurology|April 5, 2008
NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsySebastian Bauer, Martina Köller, Sabine Cepok, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Ebiomedicine|January 17, 2018
Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial)Björn Tackenberg, Maximilian Schneider, Franz Blaes, et al.
The Journal of Clinical Investigation|October 6, 2015
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicityIsaak Quast, Christian W Keller, Michael A Maurer, et al.
Frontiers in Immunology|July 12, 2019
Thymoma-Associated Paraneoplastic Autoimmune Multiorgan Syndrome-From Pemphigus to Lichenoid DermatitisFarzan Solimani, Roberto Maglie, Robert Pollmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2011
Sibling disability risk at onset and during disease progression in familial multiple sclerosisAnne Wellek, Catharina Korsukewitz, Jan P Bach, et al.
International Immunology|January 8, 2011
Impaired IFN-γ production and proliferation of NK cells in multiple sclerosisAnna Lünemann, Björn Tackenberg, Tracy DeAngelis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2025
Speech as a digital biomarker in multiple sclerosis: Automatic analysis of speech metrics using a multi-speech-task protocol in a cross-sectional MS cohort studySusett Garthof, Simona Schäfer, Julia Elmers, et al.
BMC Neurology|July 14, 2016
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumabTjalf Ziemssen, Achim Gass, Jens Wuerfel, et al.
Journal of Neurology|February 18, 2016
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological SocietyNico Melzer, Tobias Ruck, Peter Fuhr, et al.
The New England Journal of Medicine|July 13, 2012
Potassium channel KIR4.1 as an immune target in multiple sclerosisRajneesh Srivastava, Muhammad Aslam, Sudhakar Reddy Kalluri, et al.
Experimental Neurology|April 5, 2008
NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsySebastian Bauer, Martina Köller, Sabine Cepok, et al.
Pageof 9